Lo.G protects medicines in transit
LIVE FROM TOTAL PROCESS & PACKAGING
The Lo.G protects products in transit with the help of a patented 360° impact absorbing buffer system, which ensures that contents are centrally cushioned and protected.
Lo.G packs are made from recycled HDPE plastic. As a nesting product, they offer weight, space and energy savings throughout the supply chain, from warehousing to point-of-sale, when compared with EPS block or foam protective packaging.
Plastique of Tunbridge Wells, Kent offers the Lo.G packaging in single piece ‘wrap-round and lock’ boxes or end cap formats to suit a variety of products.
The company also unveiled Paperlite rPET material developed by Flextrus of Sweden, which is an alternative to thermoformed plastic trays.
According to Plastique’s sales and marketing executive, Daryl Thompson, PaperLite can be used for packaging drugs or medical devices. The material, which looks and feels like paper, is based on FibreForm from Billerud and will run on existing form fill and seal lines. It is also FSC certified and has environmental advantages over thermoformed plastic trays.
PaperLite won the Packaging Innovation Award 2009 at the Scanpack exhibition in Gothenburg.
You may also like
Research & Development
![Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines]()
Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines
Read moreAdragos Pharma Kawagoe KK has announced the signing of an agreement with Towa Pharmaceutical Co., Ltd, to establish a strategic collaboration aimed at ensuring the stable supply of off-patent pharmaceuticals
Trending Articles
You may also like
Research & Development
![Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines]()
Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines
Adragos Pharma Kawagoe KK has announced the signing of an agreement with Towa Pharmaceutical Co., Ltd, to establish a strategic collaboration aimed at ensuring the stable supply of off-patent pharmaceuticals
Cell & Gene Therapy
![Vitalant adds NGS testing to Pittsburgh lab as part of national cell and gene therapy strategy]()
Vitalant adds NGS testing to Pittsburgh lab as part of national cell and gene therapy strategy
The expansion connects Phoenix, San Francisco and Pittsburgh laboratories into a hub-and-spoke model, strengthening analytical support for CGT development, transfusion medicine and inherited bleeding disorder diagnostics
Marketing
![CPHI Milan introduces new specialist AI, cold chain, contamination control and labelling zones at this year's event]()
CPHI Milan introduces new specialist AI, cold chain, contamination control and labelling zones at this year's event
CPHI Milan 2026, one of the pharmaceutical industry's largest global events, has launched four specialist zones designed to connect pharmaceutical companies with the technologies, services and expertise shaping the future of healthcare manufacturing and supply chains
Analysis
![AP Connect 4.0 strengthens data management and traceability in connected laboratories]()
AP Connect 4.0 strengthens data management and traceability in connected laboratories
Anton Paar has announced the latest update of its lab execution system, AP Connect 4.0, featuring enhanced capabilities for centralised user management, secure data handling, and improved traceability across laboratory workflows
